Manufacturer record
Rachil Pharma: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Rachil Pharma were declared Not of Standard Quality between June 2020 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: L-RT25187, Telmisartan & Hydrochlorothiazide Tablets IP (exp Apr 2027). CDL, Kolkata (CDSCO lab) found it not of standard quality: The sample does not conform to IP with respect to the Test of Dissolution of Hydrochlorothiazide. Listed in the February 2026 alert.
Records by type
5 records linked to Rachil Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Telmisartan & Hydrochlorothiazide Tablets IP | Batch L-RT25187Mfg May 2025 · Exp Apr 2027 | The sample does not conform to IP with respect to the Test of Dissolution of Hydrochlorothiazide.Dissolution | CDL, KolkataCDSCO lab | Feb 2026 |
| Telmisartan & Hydrochlorothiazide Tablets | Batch L-RT25187Mfg May 2025 · Exp Apr 2027 | Test of Dissolution of HydrochlorothiazideDissolution | CDL, KolkataState lab | Feb 2026 |
| Calcium Carbonate, Vitamin D3 and L- Lysine Suspension (Oscaid Suspension) | Batch RL22070Mfg Aug 2022 · Exp Jul 2024 | Description, Identification and Assay of Vitamin D3Assay | RDTL ChandigarhState lab | Feb 2024 |
| Levocetirizine Dihydrochloride & Montelukast Tablets (Tesact- M Tablets) | Batch RT22464Mfg Jul 2022 · Exp Jun 2024 | Dissolution (Levocetirizine Dihydrochloride)Dissolution | RDTL GuwahatiState lab | Jan 2024 |
| Auditon-MD 8 Tablets (Ondansetron Orally Disintegrating Tablets IP 8 mg) | Batch RT181032Mfg Oct 2018 · Exp Sep 2020 | Description & DisintegrationDescription | CDL KolkataCDSCO lab | Jun 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.